Your browser doesn't support javascript.
loading
Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study.
Valpione, Sara; Carlino, Matteo S; Mangana, Johanna; Mooradian, Meghan J; McArthur, Grant; Schadendorf, Dirk; Hauschild, Axel; Menzies, Alexander M; Arance, Ana; Ascierto, Paolo A; Di Giacomo, AnnaMaria; de Rosa, Francesco; Larkin, James; Park, John J; Goldinger, Simone M; Sullivan, Ryan J; Xu, Wen; Livingstone, Elisabeth; Weichenthal, Michael; Rai, Rajat; Gaba, Lydia; Long, Georgina V; Lorigan, Paul.
Afiliação
  • Valpione S; The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK; CRUK Manchester Institute, Manchester, UK.
  • Carlino MS; Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Westmead and Blacktown Hospitals, Westmead, Australia.
  • Mangana J; University Hospital of Zurich, Zurich, Switzerland.
  • Mooradian MJ; Massachusetts General Hospital, Cancer Center, Boston, MA, USA.
  • McArthur G; Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia.
  • Schadendorf D; University Hospital Essen, Essen and German Cancer Consortium, Germany.
  • Hauschild A; Schleswig-Holstein University Hospital, Kiel, Germany.
  • Menzies AM; Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Australia.
  • Arance A; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Ascierto PA; Istituto Nazionale Tumori "Fondazione G. Pascale"-IRCCS, Naples, Italy.
  • Di Giacomo A; Medical Oncology and Immunotherapy University Hospital of Siena, Siena, Italy.
  • de Rosa F; IRCCS - IRST (Istituto Scientifico Romagnolo per Lo Studio e La Cura Dei Tumori), Meldola, Italy.
  • Larkin J; The Royal Marsden NHS Foundation Trust, London, UK.
  • Park JJ; Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Westmead and Blacktown Hospitals, Westmead, Australia.
  • Goldinger SM; University Hospital of Zurich, Zurich, Switzerland.
  • Sullivan RJ; Massachusetts General Hospital, Cancer Center, Boston, MA, USA.
  • Xu W; Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Australia.
  • Livingstone E; University Hospital Essen, Essen and German Cancer Consortium, Germany.
  • Weichenthal M; Schleswig-Holstein University Hospital, Kiel, Germany.
  • Rai R; Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia.
  • Gaba L; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Long GV; Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Australia.
  • Lorigan P; The Christie NHS Foundation Trust, and University of Manchester, Manchester, UK. Electronic address: paul.lorigan@christie.nhs.uk.
Eur J Cancer ; 91: 116-124, 2018 03.
Article em En | MEDLINE | ID: mdl-29360604

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Aged80 País/Região como assunto: America do norte / Europa / Oceania Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Melanoma Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Aged80 País/Região como assunto: America do norte / Europa / Oceania Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido